The widespread application of implantable materials has brought about a corresponding increase in implant-related complications, with implant-associated infections being the most critical. Biofilms, which often form on these implants, can significantly impede the effectiveness of traditional antibiotic therapies. Therefore, strategies such as surgical removal of infected implants and prolonged antibiotic treatment have been acknowledged as effective measures to eradicate these infections. However,the challenges of antibiotic resistance and biofilm persistence often result in recurrent or hard-to-control infections, posing severe health threats to patients. Recent studies suggest that phages, a type of virus, can directly eliminate pathogenic bacteria and degrade biofilms. Furthermore, clinical trials have demonstrated promising therapeutic results with the combined use of phages and antibiotics. Consequently, this innovative therapy holds significant potential as an effective solution for managing implant-associated infections. This paper rigorously investigates and evaluates the potential value of phage therapy in addressing orthopedic implant-associated infections, based on a comprehensive review of relevant scientific literature.
随着植入材料在骨科疾病治疗中的应用逐渐普及，植入物相关并发症日益增多，其中以感染为最为严重。采取手术取出感染植入物并延长抗菌药物用药时间已被视为根除感染的有效策略。然而，由于抗菌药物耐药和生物膜的存在，感染难以控制或复发的情况屡见不鲜，对患者健康构成严重威胁。最新研究结果显示，噬菌体不仅可以直接杀灭致病菌，还具备降解生物膜的能力。联合使用噬菌体和抗菌药物，在临床试验中展现出了良好的治疗效果，有望成为处理植入物相关感染的有效解决方案。.